NewGenIvf Group (NIVF) shares soared more than 71% in Monday's premarket activity after the company said it has signed a binding term sheet with White Lion Capital for a $100 million equity line of credit that is expandable to $500 million.
Under the terms of the agreement, the company said it will have the option to sell to White Lion up to $100 million in shares of common stock over an initial 36-month period.
NewGenIvf said the $100 million limit could rise to $300 million for mergers and acquisitions activity, and further to $500 million after $250 million has been drawn.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。